Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 5
2005 4
2006 3
2007 7
2008 9
2009 6
2010 11
2011 17
2012 7
2013 11
2014 14
2015 18
2016 14
2017 14
2018 21
2019 19
2020 13
2021 17
2022 5
2023 14
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean eun sok kim[Author] (22 results)?
C-Reactive Protein Signaling Pathways in Tumor Progression.
Kim ES, Kim SY, Moon A. Kim ES, et al. Biomol Ther (Seoul). 2023 Sep 1;31(5):473-483. doi: 10.4062/biomolther.2023.132. Epub 2023 Aug 11. Biomol Ther (Seoul). 2023. PMID: 37562952 Free PMC article. Review.
USP37 Deubiquitinates CDC73 in HPT-JT Syndrome.
Kim SY, Lee JY, Cho YJ, Jo KH, Kim ES, Han JH, Baek KH, Moon SD. Kim SY, et al. Among authors: kim es. Int J Mol Sci. 2022 Jun 7;23(12):6364. doi: 10.3390/ijms23126364. Int J Mol Sci. 2022. PMID: 35742816 Free PMC article.
Cytotoxic Peptaibols from Trichoderma strigosum.
Park YS, Kim ES, Deyrup ST, Lee JW, Shim SH. Park YS, et al. Among authors: kim es. J Nat Prod. 2024 Aug 23;87(8):2081-2094. doi: 10.1021/acs.jnatprod.4c00590. Epub 2024 Jul 22. J Nat Prod. 2024. PMID: 39038494
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension.
Moon JS, Park IR, Kim HJ, Chung CH, Won KC, Han KA, Park CY, Won JC, Kim DJ, Koh GP, Kim ES, Yu JM, Hong EG, Lee CB, Yoon KH. Moon JS, et al. Among authors: kim es. Diabetes Metab J. 2023 Nov;47(6):808-817. doi: 10.4093/dmj.2022.0387. Epub 2023 Sep 26. Diabetes Metab J. 2023. PMID: 37750183 Free PMC article. Clinical Trial.
208 results